Tower Research Capital (TRC)’s The Valens Company, Inc. Common Shares VLNS Stock Holding History

Tower Research Capital (TRC)’s Portfolio VLNS Stock Details VLNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-24,728	Closed	-$17K	–	6745
2022 Q4	$17K	Buy	24,728 +20,130	+438%	+$15.3K	﹤0.01%	3308
2022 Q3	$3K	Sell	4,598 -3,913	-46%	-$3.16K	﹤0.01%	5488
2022 Q2	$5K	Buy	8,511 +3,606	+74%	+$3.29K	﹤0.01%	5147
2022 Q1	$8K	Buy	4,905 +4,364	+807%	+$9.31K	﹤0.01%	4655
2021 Q4	$1K	Buy	+541	New	+$1.48K	﹤0.01%	6001

Tower Research Capital (TRC)'s VLNS Position: Q1 2023 in Review

Tower Research Capital (TRC) sold out of The Valens Company, Inc. Common Shares (VLNS) in Q1 2023, closing a stake of 24,728 shares — an estimated $17K sold.

Tower Research Capital (TRC) first reported a position in VLNS in Q4 2021 and held it in 5 quarters. The position peaked at $17K in Q4 2022. 0 funds tracked by Wall St. Rank hold VLNS as of Q1 2023.

Tower Research Capital (TRC) reported no remaining The Valens Company, Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
Tower Research Capital (TRC) sold 24,728 The Valens Company, Inc. Common Shares shares in Q1 2023, an estimated $17K.
Tower Research Capital (TRC) first reported a position in The Valens Company, Inc. Common Shares in Q4 2021 and held it in 5 quarters.
Tower Research Capital (TRC)'s The Valens Company, Inc. Common Shares position peaked at $17K in Q4 2022.
0 funds tracked by Wall St. Rank held The Valens Company, Inc. Common Shares as of Q1 2023.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.